AAAAAA
Results:
1-18
|
Results: 18
Authors:
Berdeja, JG
Jones, RJ
Zahurak, ML
Piantadosi, S
Abrams, RA
Borowitz, MJ
Vogelsang, GB
Noga, SJ
Ambinder, RF
Flinn, IW
Citation: Jg. Berdeja et al., Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma, BIOL BLOOD, 7(10), 2001, pp. 561-567
Authors:
Waselenko, JK
Shinn, CA
Willis, CR
Flinn, IW
Grever, MR
Byrd, JC
Citation: Jk. Waselenko et al., Carboxyamido-triazole (CAI)- a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells, LEUK LYMPH, 42(5), 2001, pp. 1049-1053
Authors:
Flinn, IW
Citation: Iw. Flinn, Lymphoma, CURR OPIN O, 13(5), 2001, pp. 315-315
Authors:
Berdeja, JG
Flinn, IW
Citation: Jg. Berdeja et Iw. Flinn, New approaches to blood and marrow transplantation for patients with low-grade lymphomas, CURR OPIN O, 13(5), 2001, pp. 335-341
Authors:
Byrd, JC
Murphy, T
Howard, RS
Lucas, MS
Goodrich, A
Park, K
Pearson, M
Waselenko, JK
Ling, G
Grever, MR
Grillo-Lopez, AJ
Rosenberg, J
Kunkel, L
Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164
Authors:
Akpek, G
Ambinder, RF
Piantadosi, S
Abrams, RA
Brodsky, RA
Vogelsang, GB
Zahurak, ML
Fuller, D
Miller, CB
Noga, SJ
Fuchs, E
Flinn, IW
O'Donnell, P
Seifter, EJ
Mann, RB
Jones, RJ
Citation: G. Akpek et al., Long-term results of blood and marrow transplantation for Hodgkin's lymphoma, J CL ONCOL, 19(23), 2001, pp. 4314-4321
Authors:
Byrd, JC
Shinn, C
Willis, CR
Flinn, IW
Lehman, T
Suasville, E
Lucas, D
Gerver, MR
Citation: Jc. Byrd et al., UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism, EXP HEMATOL, 29(6), 2001, pp. 703-708
Authors:
Flinn, IW
Lazarus, HM
Citation: Iw. Flinn et Hm. Lazarus, Monoclonal antibodies and autologous stem cell transplantation for lymphoma, BONE MAR TR, 27(6), 2001, pp. 565-569
Authors:
Waselenko, JK
Grever, MR
Shinn, CA
Flinn, IW
Byrd, JC
Citation: Jk. Waselenko et al., Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia, LEUK RES, 25(6), 2001, pp. 435-440
Authors:
Flinn, IW
O'Donnell, PV
Goodrich, A
Vogelsang, G
Abrams, R
Noga, S
Marcellus, D
Borowitz, M
Jones, R
Ambinder, RF
Citation: Iw. Flinn et al., Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma, BIOL BLOOD, 6(6), 2000, pp. 628-632
Authors:
Flinn, IW
Goodman, SN
Post, L
Jamison, J
Miller, CB
Gore, S
Diehl, L
Willis, C
Ambinder, RF
Byrd, JC
Citation: Iw. Flinn et al., A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL, ANN ONCOL, 11(6), 2000, pp. 691-695
Authors:
Margolis, J
Borrello, I
Flinn, IW
Citation: J. Margolis et al., New approaches to treating malignances with stem cell transplantation, SEMIN ONCOL, 27(5), 2000, pp. 524-530
Authors:
Byrd, JC
Grever, MR
Waselenko, JK
Willis, CR
Park, K
Goodrich, A
Lucas, MA
Shinn, C
Flinn, IW
Citation: Jc. Byrd et al., Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders, SEMIN ONCOL, 27(2), 2000, pp. 37-40
Authors:
Flinn, IW
Kopecky, KJ
Foucar, MK
Head, D
Bennett, JM
Huchison, R
Corbett, W
Cassileth, P
Habermann, T
Golomb, H
Rai, K
Eisenhauer, E
Appelbaum, F
Cheson, B
Grever, MR
Citation: Iw. Flinn et al., Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin, BLOOD, 96(9), 2000, pp. 2981-2986
Authors:
Yang, J
Tao, Q
Flinn, IW
Murray, PG
Post, LE
Ma, H
Piantadosi, S
Caligiuri, MA
Ambinder, RF
Citation: J. Yang et al., Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response, BLOOD, 96(13), 2000, pp. 4055-4063
Authors:
Flinn, IW
Byrd, JC
Morrison, C
Jamison, J
Diehl, LF
Murphy, T
Piantadosi, S
Seifter, E
Ambinder, RF
Vogelsang, G
Grever, MR
Citation: Iw. Flinn et al., Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies, BLOOD, 96(1), 2000, pp. 71-75
Authors:
Yang, J
Lemas, VM
Flinn, IW
Krone, C
Ambinder, RF
Citation: J. Yang et al., Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens, BLOOD, 95(1), 2000, pp. 241-248
Authors:
Byrd, JC
Shinn, C
Ravi, R
Willis, CR
Waselenko, JK
Flinn, IW
Dawson, NA
Grever, MR
Citation: Jc. Byrd et al., Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells, BLOOD, 94(4), 1999, pp. 1401-1408
Risultati:
1-18
|